Identification of novel pharmacological activities of an antifungal agent, nystatin, to promote dendritic cell maturation

Journal of Investigative Dermatology

Volumn 126, Issue 2, 2006, Pages 349-353

  Ogawa, Yasushi ^a   Mizumoto, Norikatsu ^a   Tanaka, Hiroaki ^a   Matsushima, Hironori ^a   Takashima, Akira ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NYSTATIN; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR REL; TUMOR NECROSIS FACTOR ALPHA; YELLOW FLUORESCENT PROTEIN;

ANIMAL CELL; ARTICLE; BIOSENSOR; CELL ACTIVATION; CELL MATURATION; DENDRITIC CELL; DRUG ACTIVITY; DRUG MECHANISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIFUNGAL AGENTS; ANTIGENS, CD; BACTERIAL PROTEINS; CELL DIFFERENTIATION; CELL LINE; CYTOKINES; DENDRITIC CELLS; INTERLEUKIN-1; LUMINESCENT PROTEINS; MICE; NYSTATIN; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-REL; TRANSCRIPTION FACTOR RELA;

EID: 33644645364     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700081     Document Type: Article

References (27)

1. Anderson HA, Hiltbold EM, Roche PA (2000) Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat Immunol 1:156-62
2. Ashman RB, Farah CS, Wanasaengsakul S, Hu Y, Pang C, Clancy RL (2004) Innate versus adaptive immunity in Candida albicans infection. Immunol Cell Biol 82:196-204
3. Bacci A, Montagnoli C, Perruccio K, Bozza S, Gaziano R, Pitzurra L et al. (2002) Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J Immunol 168:2904-13
4. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245-52
5. Bolard J (1986) How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim Biophys Acta 864:257-304
6. Coutinho A, Silva L, Fedorov A, Prieto M (2004) Cholesterol and ergosterol influence nystatin surface aggregation: relation to pore formation. Biophys J 87:3264-76
7. Delmas D, Rébé C, Micheau O, Athias A, Gambert P, Grazide S et al. (2004) Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. Oncogene 23:8979-86
8. d'Ostiani CF, Del Sero G, Bacci A, Montagnoli C, Spreca A, Mencacci A et al. (2000) Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med 191:1661-74
9. Giannoukakis N, Bonham CA, Qian S, Chen Z, Peng L, Harnaha J et al. (2000) Prolongation of cardiac allograft survival using dendritic cells treated with NF-κB decoy oligodeoxyribonucleotides. Mol Ther 1:430-7
10. Ishikawa H, Narimatsu H, Saito K (1977) Mechanisms of the adjuvant effect of nystatin on in vitro antibody response of mouse spleen cells: indication of nystatin as a B-cell mitogen and as a stimulant for polyclonal antibody synthesis in B cells. Microbiol Immunol 21:137-52
11. Klein DL, Aszalos A, Pearson JW (1980) Macrophage cytostasis and T and B cell blastogenic transformation in mice treated with nystatin. J Immunopharmacol 2:367-80
12. Kobayashi GS, Medoff G (1977) Antifungal agents: recent developments. Annu Rev Microbiol 31:291-308
13. Lacour S, Hammann A, Grazide S, Lagadic-Gossmann D, Athias A, Sergent O et al. (2004) Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. Cancer Res 64:3593-8
14. Larrengina AT, Falo LD (2005) Changing paradigms in cutaneous immunology: adapting with dendritic cells. J Invest Dermatol 124:1-12
15. Meyer zum Bueschenfelde CO, Unternaehrer J, Mellman I, Bottomly K (2004) Regulated recruitment of MHC class II and costimulatory molecules to lipid rafts in dendritic cells. J Immunol 173:6119-24
16. Mizumoto N, Gao J, Matsushima H, Ogawa Y, Tanaka H, Takashima A (2005a) Discovery of novel immunostimulants by dendritic cell-based functional screening. Blood 106:3082-9
17. Mizumoto N, Hui F, Edelbaum D, Weil MR, Wren JD, Shalhevet D et al. (2005b) Differential activation profiles of multiple transcription factors during dendritic cell maturation. J Invest Dermatol 124:718-24
18. Mueller A, Kelly E, Strange PG (2002) Pathways for internalization and recycling of the chemokine receptor CCR5. Blood 99:785-91
19. Prevostel C, Alice V, Joubert D, Parker PJ (2000) Protein kinase Cα actively downregulates through caveolae-dependent traffic to an endosomal compartment. J Cell Sci 113(Part 14):2575-84
20. Pucadyil TJ, Shrivastava S, Chattopadhyay A (2004) The sterol-binding antibiotic nystatin differentially modulates ligand binding of the bovine hippocampal serotonin1A receptor. Biochem Biophys Res Commun 320:557-62
21. Pulendran B (2005) Variegation of the immune response with dendritic cells and pathogen recognition receptors. J Immunol 174:2457-65
22. Romani L (1999) Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol 2:363-7
23. Romani N, Holzmann S, Tripp CH, Koch F, Stoitzner P (2003) Langerhans cells - dendritic cells of the epidermis. Apmis 111:725-40
24. Shirley SF, Little JR (1979a) Immunopotentiating effects of amphotericin B. I. Enhanced contact sensitivity in mice. J Immunol 123:2878-82
25. Shirley SF, Little JR (1979b) Immunopotentiating effects of amphotericin B. II. Enhanced in vitro proliferative responses of murine lymphocytes. J Immunol 123:2883-9
26. Wiegand R, Betz M, Hansch GM (1988) Nystatin stimulates prostaglandin E synthesis and formation of diacylglycerol in human monocytes. Agents Actions 24:343-50
27. Yoshimura S, Bondeson J, Brennan FM, Foxwell BM, Feldmann M (2001) Role of NFκB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI. Eur J Immunol 31:1883-93